New Therapies
Repurposed drug brings new hope for breast cancer patients
June 20, 2024
Could a drug prescribed for transplant recipients also help some women beat breast cancer? Impressive new findings point to this possibility, according to research conducted at The University of Texas Health Science Center at San Antonio that is now being used in a clinical trial supported by funding from the National Institutes of Health and the Mays Cancer Center.
A year of transformative progress
May 13, 2023
UT Health San Antonio’s Joe R. and Teresa Lozano Long School of Medicine Dean Robert Hromas, MD, identifies four areas of focus of the Mays Cancer Center in its quest to end cancer for communities in South Texas and beyond.
The intersection of research and practice
May 13, 2023
The Mays Cancer Center is testing new treatments to enhance and extend the life of patients with cancer and translating leading-edge research into new drugs and technology-assisted procedures that are improving patient health and recovery.
NIH grant to boost ovarian cancer drug development
May 13, 2023
The Mays Cancer Center and Evestra Inc., a San Antonio, Texas-based biopharmaceutical company, have been awarded a five-year, $3.3 million Academic Industry Partnership grant from the National Institutes of Health.
Exploring technological advances in patient treatment
May 13, 2023
Mays Cancer Center is at the forefront of technology-assisted surgical treatments that are improving patient recovery.
Cryo-EM technology brings the study of tumors to a molecular level
May 13, 2023
UT Health San Antonio is investing $5 million over the next three years in cryo-electron microscopy technology that will help investigators of the Mays Cancer Center study tumors and help researchers of the Greehey Children’s Cancer Research Institute to study childhood cancers.